Dual Immunization Against RSV With RSVpreF and Nirsevimab
This cohort study aimed to describe RSV-associated lower respiratory tract infection hospitalizations among infants in France who received both maternal RSV-preF vaccination and nirsevimab during the 2024-2025 RSV season.
Authors
- A. Gabet (ORCID: https://orcid.org/0000-0003-1273-8988)
- Marion Bertrand (ORCID: https://orcid.org/0000-0002-4115-7093)
- Valérie Olié (ORCID: https://orcid.org/0000-0002-4837-1930)
- Ludovic Tréluyer (ORCID: https://orcid.org/0000-0001-8171-1311)
- Antoine Rachas
- Marie-Joelle Jabagi
- Epiphane Kolla
- Mahmoud Zureik
Institutions
- Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail (FR)
Publication Details
- Journal
- JAMA Pediatrics
- Published
- 2026-05-18
- DOI
- https://doi.org/10.1001/jamapediatrics.2026.1346
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00